These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 1690184

  • 1. Biodistribution and magnetic resonance imaging of cross-linked DTPA polysaccharides.
    Gibby WA, Billings J, Hall J, Ovitt TW.
    Invest Radiol; 1990 Feb; 25(2):164-72. PubMed ID: 1690184
    [Abstract] [Full Text] [Related]

  • 2. Effect of varying the molecular weight of the MR contrast agent Gd-DTPA-polylysine on blood pharmacokinetics and enhancement patterns.
    Vexler VS, Clément O, Schmitt-Willich H, Brasch RC.
    J Magn Reson Imaging; 1994 Feb; 4(3):381-8. PubMed ID: 8061437
    [Abstract] [Full Text] [Related]

  • 3. The relaxivity of Gd-EOB-DTPA and Gd-DTPA in liver and kidney of the Wistar rat.
    Shuter B, Tofts PS, Wang SC, Pope JM.
    Magn Reson Imaging; 1996 Feb; 14(3):243-53. PubMed ID: 8725190
    [Abstract] [Full Text] [Related]

  • 4. Hepatic kinetics and magnetic resonance imaging of gadolinium ethoxybenzyl diethylenetriaminepentacetic acid (Gd-EOB-DTPA) in dogs.
    Benness G, Khangure M, Morris I, Warwick A, Burrows P.
    Australas Radiol; 1993 Aug; 37(3):252-5. PubMed ID: 8373327
    [Abstract] [Full Text] [Related]

  • 5. Dynamic contrast-enhanced magnetic resonance imaging of the breast combined with pharmacokinetic analysis of gadolinium-DTPA uptake in the diagnosis of local recurrence of early stage breast carcinoma.
    Mussurakis S, Buckley DL, Bowsley SJ, Carleton PJ, Fox JN, Turnbull LW, Horsman A.
    Invest Radiol; 1995 Nov; 30(11):650-62. PubMed ID: 8557506
    [Abstract] [Full Text] [Related]

  • 6. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats.
    Clément O, Mühler A, Vexler V, Berthezène Y, Brasch RC.
    Invest Radiol; 1992 Aug; 27(8):612-9. PubMed ID: 1428739
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evaluation of Gd-DTPA-labeled dextran as an intravascular MR contrast agent: imaging characteristics in normal rat tissues.
    Wang SC, Wikström MG, White DL, Klaveness J, Holtz E, Rongved P, Moseley ME, Brasch RC.
    Radiology; 1990 May; 175(2):483-8. PubMed ID: 1691513
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. MR contrast enhancement of intracranial lesions with Gd-DTPA.
    Hesselink JR, Press GA.
    Radiol Clin North Am; 1988 Jul; 26(4):873-87. PubMed ID: 3289078
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Paradoxic uptake of Gd-EOB-DTPA by hepatocellular carcinoma in mice: quantitative image analysis.
    Fujita M, Yamamoto R, Takahashi M, Tsuji T, Yamanaka T, Miyazawa T, Fritz-Zieroth B, Terada N, Kuroda C.
    J Magn Reson Imaging; 1997 Jul; 7(4):768-70. PubMed ID: 9243401
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Tissue relaxation enhancement after intravenous administration of (ITCB-DTPA)-gadolinum conjugated albumin, an intravascular magnetic resonance imaging contrast agent.
    Niemi P, Koskinen S, Reisto T.
    Invest Radiol; 1991 Jul; 26(7):674-80. PubMed ID: 1885276
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.